Skip to main content

Table 1 Country-specific profiles of the 72 GAVI-eligible countries

From: Health and economic impact of rotavirus vaccination in GAVI-eligible countries

Countrya

GNI per capita (2008 US$)

GAVI grouping for co-financingb

DTP3 coverage (2008)

Under 5 child mortality (per 1,000 live births) (2006)

Under 5 rotavirus mortality (per 100000 children <5) (2004)

Percentage of death due to diarrhea among children under 5 (2000)

AFR D

      

   Angola

3,450

4

81%

260

389

19.1

   Benin

690

1

93%

148

182

17.1

   Burkina Faso

480

1

99%

204

256

18.8

   Cameroon

1,150

3

84%

149

179

17.3

   Chad

530

1

43%

209

266

18.1

   Comoros

750

1

81%

68

64

13.6

   Ghana

670

2

87%

120

92

12.2

   Guinea

390

1

70%

161

188

16.5

   Guinea-Bissau

250

1

79%

200

283

18.6

   Liberia

170

4

92%

235

331

17.3

   Madagascar

410

1

88%

115

141

16.9

   Mali

580

1

99%

217

307

18.3

   Mauritania

840

1

74%

125

153

16.2

   Niger

330

1

89%

253

392

19.8

   Nigeria

1,160

2

57%

191

228

15.7

   Sao Thome

1,020

1

99%

96

129

16.0

   Senegal

970

1

88%

116

158

17.1

   Sierra Leone

320

4

87%

269

439

19.7

   The Gambia

390

1

96%

114

107

12.2

   Togo

400

1

89%

107

134

13.8

AFR E

      

   Burundi

140

4

92%

181

255

18.2

   Central African Republic

410

4

51%

174

210

14.7

   Congo

1,970

4

89%

126

86

11.2

   Cote d'Ivoire

980

4

74%

127

223

14.8

   Democratic Republic of the Congo

150

4

83%

205

281

18.1

   Eritrea

300

4

85%

74

84

15.6

   Ethiopia

280

1

81%

123

213

17.3

   Kenya

770

2

85%

121

135

16.5

   Lesotho

1,080

1

91%

132

25

3.9

   Malawi

290

1

91%

120

225

18.1

   Mozambique

370

1

80%

138

183

16.5

   Rwanda

410

1

97%

160

272

18.5

   Tanzania

430

1

84%

118

147

16.8

   Uganda

420

1

79%

134

165

17.2

   Zambia

950

1

95%

182

227

17.5

   Zimbabwe

c

2

75%

85

106

12.1

AMR A, B & D

      

   Cuba

c

2

99%

7

1

1.3

   Guyana

1,420

3

93%

62

119

21.4

   Honduras

1,800

3

93%

27

43

12.2

   Bolivia

1,460

3

83%

61

66

14.3

   Haiti

660

4

53%

80

133

16.5

   Nicaragua

1,080

2

96%

26

30

12.2

EMR D

      

   Afghanistan

c

4

85%

257

338

18.9

   Djibouti

1,130

3

89%

130

145

16.6

   Pakistan

980

2

73%

97

95

14.0

   Somalia

c

4

31%

145

315

18.7

   Sudan

1,130

4

93%

89

79

12.9

   Yemen

950

1

87%

100

108

16.1

EUR B & C

      

   Armenia

3,350

3

89%

24

29

10.5

   Azerbaijan

3,830

3

95%

89

125

15.3

   Georgia

2,470

3

92%

32

42

11.5

   Kyrgyzstan

740

2

95%

41

86

14.1

   Tajikistan

600

2

86%

68

177

16.4

   Uzbekistan

910

2

98%

44

88

14.8

   Moldova

1,470

2

95%

19

5

2.0

   Ukraine

3,210

3

90%

24

2

1.2

SEAR B & D

      

   Indonesia

2,010

3

77%

34

60

18.3

   Korea, Democratic Republic

c

2

92%

55

56

18.9

   Sri Lanka

1,790

3

98%

13

16

13.5

   Timor Leste

2,460

4

79%

55

115

21.9

   Bangladesh

520

1

87%

69

89

20.0

   Bhutan

1,900

1

96%

70

98

20.9

   India

1,070

2

84%

76

102

20.3

   Myanmar

c

1

85%

104

128

21.1

   Nepal

400

1

82%

59

91

20.5

WPR B

      

   Cambodia

600

1

91%

82

226

16.6

   Kiribati

2,000

3

82%

64

127

21.9

   Lao People Democratic Republic

750

1

61%

75

122

15.6

   Mongolia

1,680

2

96%

42

67

14.5

   Papua New Guinea

1,010

2

52%

73

128

15.3

   Solomon Islands

1,180

1

78%

72

45

8.8

   Viet Nam

890

2

93%

17

21

10.4

  1. a The six WHO geographical regions are the African Region (AFR), Eastern Mediterranean Region (EMR), Region of the Americas (AMR), European Region (EUR), South-East Asian Region (SEAR), and Western Pacific Region (WPR). Categories for mortality rates include very low child, very low adult mortality (A), low child, low adult mortality (B), low child, high adult mortality (C), high child, high adult mortality (D), and high child and very high adult mortality (E). Combining the two dimensions, we modeled 36 countries from AFR (with 20 in AFR D and 16 in AFR E); 6 countries from EMR D; 6 countries from AMR A, B & D; 8 countries from EUR B & C; 9 countries from SEAR B & D; and 7 countries from WPR B.
  2. b The GAVI Alliance new vaccine co-financing policy (which came into effect in 2008) requires GAVI-eligible countries to share new vaccine costs at one of four levels depending on the country's ability to pay: (1) Poorest group countries will pay $0.20/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines; (2) Intermediate group countries will pay $0.30/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines; (3) Least Poor group countries will pay $0.20/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines for the first year, but will increase their copayment by 15% annually; and (4) Fragile group countries will pay $0.10/dose of the first vaccine and $0.15/dose for the 2nd and 3rd vaccines.
  3. c Data are not available.